Adrienne Monson – Lifestyle
Author:
BERRY & COMPANY PUBLIC RELATIONS
GRIN Therapeutics’ Pivotal Phase 3 Beeline Study Initiated in Europe
May 4, 2026
ITF Therapeutics LLC Presents New Data and Analyses on Givinostat for Treatment of Duchenne Muscular Dystrophy at 2026 MDA Clinical and Scientific Conference
March 9, 2026